Ribonexus

Ribonexus

A biotechnology startup developing promising new therapies that can overcome resistance to current targeted therapies in cancer patients. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€16—24m (Dealroom.co estimates Sep 2021.)
Company register number 898280250
Villejuif Île-de-France (HQ)
Authorizing premium user...